The total French market represents €95M. 58% of this amount is generated in private hospitals. Autoexpandable and balloon stents come to 58% of the total market ; (+3.3%, 2019 vs 2018). Boston Scientific and Becton & Dickinson (BD, ex Bard) strongly increased their shares on Drug Eluting Balloon market. To get the full report, please contact-us : inquiries@ihmt-medicaldevice.com #France #Peripheral #Interventional #Vascular #Endovascular #Angioplasty #Market #Shares #Hospital

DES market revenues have been flatenning over the past 3 years. In 2019, DES national tariffs (LPPR) decreased of -17.1% (€760 to €630) even though it doesn't reflect real-life tariffs, especially in public hospitals where prices are much lower. Consequently we observe a drop of -3.4% in total revenues (2018 vs 2019 : €201M.). To get the full report, please contact-us : inquiries@ihmt-medicaldevice.com #DES #Coronary #Stent #Angioplasty #Heart #Interventional #Cardiology #Inf

In France, the new Patent Foramen Ovale (PFO) occluder named Amplatzer (Abbott) will be reimbursed €3,735 from June 03, 2020 #Abbott, #Exovascular #Heart #Stroke #Amplatzer #Occluder #interventional #percutaneous #PFO #LPPR #Reimbursement #Marketaccess #Listing #Listeensus #Tariff #Addonpayment #France #Remboursement #Accesaumarché #Tarif #Inscription #exovasculaire #AVC #Santé

In France, the tariffs of the covered, autoexpandable, balloon and drug eluting stents in vascular interventional market will be cut of -8.0% from July 11, 2020 (originally scheduled on 15/05/2020) #Abbott, #Bard #BD, #BBraun, #ABMEDICA, #Andramed, #Bentley, #Medcare, #Medimpulse, #Qualimed, #Vygon, #Medicut, #Biotronik, #Bostonscientific, #Cookmedical, #Cordis, #Hexacath, #Getinge, #Maquet, #Optimed #Terumo #WLGore, #Medtronic, #Endovascular #Peripheral #stent #Vascular #in

Market growth was impressive over the last 5 years. 10,851 TAVI/TAVR were implanted in ~60 hospitals (2017). Edwards Lifescience still leads the market (58.9%) vs the challenger Medtronic (41.1%). In 2019, Boston Scientific comes to the market with its Accurate device. Abbott should enter the market sometime in 2020/2021. Shares should change soon. Follow us on LinkedIn : https://lnkd.in/dfQ6ckS #Market_research #Analytics #Market_intelligence #Market_data #TAVI #TAVR #Transc

Telecardiology systems market has grown fast since 2010. MedTech Companies (#Abbott #Biotronik #Boston_Scientific #Medtronic #MicroPort) rapidely competed fiercely against each other. In 2017, We have 3 leaders with around 25% market share each. 73% of telecardiology systems are set up in public Hospitals. Most of them (46.1%) concerns triple chambers. Follow us on LinkedIn : https://lnkd.in/dfQ6ckS